Clinical Trials for Anocca

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Anocca

Clinical Trials (1)

NCT07145450
Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
PHASE1/PHASE2Recruiting
96 participants
Started: Jul 3, 2025 · Completed: Jul 31, 2030
1 condition1 sponsor8 locations